BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 588556)

  • 1. Methylation of glucagon, characterization of the sulfonium derivative, and regeneration of the native covalent structure.
    Rothgeb TM; Jones BN; Hayes DF; Gurd RS
    Biochemistry; 1977 Dec; 16(26):5813-8. PubMed ID: 588556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N alpha-Malto-glucagon and N alpha-malto, S-methyl methionine27-glucagon: preparation and characterization of two partial agonists.
    Coolican SA; Gurd RS
    Arch Biochem Biophys; 1984 Aug; 232(2):450-7. PubMed ID: 6380408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipolytic and adenyl-cyclase-stimulating activity of N alpha-trinitrophenyl glucagon: comparison with other glucagon derivatives modified at the amino terminus.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Mar; 2(3):163-7. PubMed ID: 7066487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone receptors. I. Activation of rat liver plasma membrane adenylyl cyclase and fat cell lipolysis by agarose-glucagon.
    Johnson CB; Blecher M; Giorgio NA
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1035-41. PubMed ID: 5012158
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
    Carrey EA; Epand RM
    J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
    Liepnieks JJ; Epand RM
    Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and isolation of a glucagon antagonist.
    Bregman MD; Hruby VJ
    FEBS Lett; 1979 May; 101(1):191-4. PubMed ID: 446735
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of amidinated glucagons.
    Wright DE; Rodbell M
    Eur J Biochem; 1980 Oct; 111(1):11-6. PubMed ID: 7439177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of 2-thioltryptophan-glucagon and (tryptophan-S-glucagon)2. Differences in binding to the glucagon receptor in the hepatic adenylate cyclase system.
    Wright DE; Rodbell M
    J Biol Chem; 1980 Nov; 255(22):10884-7. PubMed ID: 7430160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function relationships of S-carboxymethyl methionine27 glucagon.
    Cornely KA; Shelter KA; England RD; Horwitz EM; Gurd RS
    Arch Biochem Biophys; 1985 Aug; 240(2):698-704. PubMed ID: 2992382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon: structure-function relationships investigated by sequence deletions.
    Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of glucagon1-6: the N-terminal hexapeptide of glucagon is not biologically active in the hepatic adenylate cyclase system.
    Pelton JT; Trivedi D; Hruby VJ
    Life Sci; 1983 Sep; 33(13):1307-14. PubMed ID: 6888179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon carboxyl-terminal derivatives: preparation, purification, and characterization.
    England RD; Jones BN; Flanders KC; Coolican SA; Rothgeb TM; Gurd RS
    Biochemistry; 1982 Mar; 21(5):940-50. PubMed ID: 7074063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
    Liepnieks JJ; Epand RM
    Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization of glucagon and epinephrine sensitive adenylate cyclase from rat liver plasma membranes.
    Ryan J; Storm DR
    Biochem Biophys Res Commun; 1974 Sep; 60(1):304-11. PubMed ID: 4418132
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [25-oxindolylalanine]glucagon and [27-methionine sulfoxide]glucagon: preparation, purification, and characterization.
    Coolican SA; Jones BN; England RD; Flanders KC; Condit JD; Gurd RS
    Biochemistry; 1982 Sep; 21(20):4974-81. PubMed ID: 7138842
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-function relationships in glucagon: properties of highly purified des-His-1-, monoiodo-, and (des-Asn-28, Thr-29)(homoserine lactone-27)-glucagon.
    Lin MC; Wright DE; Hruby VJ; Rodbell M
    Biochemistry; 1975 Apr; 14(8):1559-63. PubMed ID: 164891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylglucagon: preparation and characterization.
    Desbuguois B
    Eur J Biochem; 1975 Dec; 60(2):335-47. PubMed ID: 1270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.